Thor Medical ASA Market Cap ($178.50 Million)
Market Cap & Net Worth: Thor Medical ASA (TRMED)
Thor Medical ASA market cap. Thor Medical ASA (OL:TRMED) has a market capitalization of $178.50 Million (Nkr1.70 Billion) as of November 1, 2026. Listed on the OL stock exchange, this Norway-based company holds position #16782 globally and #138 in its home market, demonstrating a -6.63% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Thor Medical ASA's stock price Nkr4.02 by its total outstanding shares 422501820 (422.50 Million). Also see TRMED cash flow metrics for how efficiently the company converts equity into cash flow.
Thor Medical ASA Market Cap History (2015–2026)
Thor Medical ASA market cap history from 2015 to 2026. Data shows change from $612.52 Million to $178.50 Million (-9.46% CAGR). Check current stock price of Thor Medical ASA for real-time trading data and today's change.
Thor Medical ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Thor Medical ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Thor Medical ASA (TRMED) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
531.69x
Thor Medical ASA's market cap is 531.69 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $233.41 Million | $439.00K | -$58.01 Million | 531.69x | N/A |
Competitor Companies of TRMED by Market Capitalization
Companies near Thor Medical ASA in the global market cap rankings as of November 1, 2026. Also see TRMED asset base for a full breakdown of the balance sheet.
Key companies related to Thor Medical ASA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Thor Medical ASA (2015–2026)
Market capitalization of Thor Medical ASA from 2015 to today. Between 2015 and today, Thor Medical ASA's market cap moved from $612.52 Million to $ 178.50 Million, with a yearly change of -9.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr178.50 Million | -23.52% |
| 2025 | Nkr233.41 Million | +99.62% |
| 2024 | Nkr116.93 Million | +103.88% |
| 2023 | Nkr57.35 Million | +9.88% |
| 2022 | Nkr52.20 Million | -94.84% |
| 2021 | Nkr1.01 Billion | +47.77% |
| 2020 | Nkr684.23 Million | -50.50% |
| 2019 | Nkr1.38 Billion | -37.60% |
| 2018 | Nkr2.22 Billion | -37.04% |
| 2017 | Nkr3.52 Billion | -16.28% |
| 2016 | Nkr4.20 Billion | +586.17% |
| 2015 | Nkr612.52 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Thor Medical ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $178.50 Million USD |
| MoneyControl | $178.50 Million USD |
| MarketWatch | $178.50 Million USD |
| marketcap.company | $178.50 Million USD |
| Reuters | $178.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Thor Medical ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.